Mavacamten-Associated Temporal Changes in Left Atrial Function in Obstructive HCM

Y. Desai, Milind; Okushi, Yuichiro; Wolski, Kathy; B. Geske, Jeffrey; Owens, Anjali; Saberi, Sara; Z. Wang, Andrew; Cremer, Paul; V. Sherrid, Mark; K. Lakdawala, Neal; Tower‐Rader, Albree; Fermin, David; S. Naidu, Srihari; Lampl, Kathy; J. Sehnert, Amy; E. Nissen, Steven; Popović, Zoran; Y. Desai, Milind; B. Geske, Jeffrey; V. Sherrid, Mark; Owens, Anjali; Saberi, Sara; Wang, Andrew; Tower-Rader, A.; Fermin, David; K. Lakdawala, Neal; Masri, Ahmad; Zenker, M.; C. Stendahl, John; T. Wheeler, Matthew; Bach, R.; Orford, J.; Naidu, Suveeksha; Rader, Florian; Bajona, Pietro

doi:10.1016/j.jcmg.2024.08.005

Public

Mavacamten-Associated Temporal Changes in Left Atrial Function in Obstructive HCM

Published in JACC. Cardiovascular imaging • Sep 2, 2024

Authors:

Milind Y. Desai

Yuichiro Okushi

Kathy Wolski

Abstract

BACKGROUND: In severely symptomatic patients with obstructive hypertrophic cardiomyopathy (HCM), the VALOR-HCM (A Study to Evaluate Mavacamten in Adults With Symptomatic Obstructive Hypertrophic Cardiomyopathy Who Are Eligible for Septal Reduction Therapy) trial showed that mavacamten reduced the el...

Subject

Cardiology

Internal medicine

Medicine

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!